Systematic review of rituximab for autoimmune diseases: a potential alternative to intravenous immune globulin. [electronic resource]
- Transfusion 11 2018
- 2729-2735 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Systematic Review
1537-2995
10.1111/trf.14841 doi
Antirheumatic Agents--therapeutic use Autoimmune Diseases--drug therapy Humans Immunoglobulins, Intravenous--therapeutic use Rituximab--therapeutic use